KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Gains from Sales and Divestitures (2017 - 2025)

Fulgent Genetics (FLGT) has disclosed Gains from Sales and Divestitures for 9 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Gains from Sales and Divestitures rose 4.48% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, up 4.48% year-over-year, with the annual reading at $1.0 million for FY2025, 4.48% up from the prior year.
  • Gains from Sales and Divestitures hit $1.0 million in Q4 2025 for Fulgent Genetics, up from $1.0 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $1.1 million in Q4 2023 to a low of $699000.0 in Q4 2022.
  • Historically, Gains from Sales and Divestitures has averaged $930800.0 across 5 years, with a median of $1.0 million in 2024.
  • Biggest five-year swings in Gains from Sales and Divestitures: dropped 16.39% in 2022 and later surged 52.5% in 2023.
  • Year by year, Gains from Sales and Divestitures stood at $836000.0 in 2021, then decreased by 16.39% to $699000.0 in 2022, then skyrocketed by 52.5% to $1.1 million in 2023, then dropped by 5.82% to $1.0 million in 2024, then rose by 4.48% to $1.0 million in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for FLGT at $1.0 million in Q4 2025, $1.0 million in Q4 2024, and $1.1 million in Q4 2023.